Japanese Diversified Financial Stock News

TSE:6981
TSE:6981Electronic

Murata Manufacturing (TSE:6981) Valuation After Raised Revenue Guidance And Earnings Update

Murata Manufacturing (TSE:6981) drew investor attention after raising its full year revenue guidance to ¥1,800,000 million, while at the same time trimming operating profit expectations and releasing nine month results to December 2025. See our latest analysis for Murata Manufacturing. Murata Manufacturing's latest guidance update and earnings release arrived after a period of mixed trading, with the share price at ¥3,269 on a 7 day share price return of 5.96% and a 1 year total shareholder...
TSE:8697
TSE:8697Capital Markets

What Japan Exchange Group (TSE:8697)'s Higher Nine-Month Profits Mean For Shareholders

Japan Exchange Group, Inc. reported past earnings for the nine months ended December 31, 2025, with sales of ¥139,626 million, revenue of ¥139,883 million, net income of ¥54,993 million, and basic earnings per share of ¥53.33, all higher than a year earlier. The simultaneous rise in sales, revenue, and earnings suggests the exchange operator converted higher business activity into stronger profitability over the period. Next, we examine how Japan Exchange Group’s improved net income profile...
TSE:7613
TSE:7613Electronic

Top 3 Asian Dividend Stocks To Enhance Your Portfolio

As Asian markets navigate a landscape marked by volatility in global technology stocks and geopolitical tensions, investors are increasingly looking towards value-oriented segments that have shown resilience. In this environment, dividend stocks can offer stability and income potential, making them an attractive option for those seeking to enhance their portfolios amidst the current market dynamics.
TSE:4568
TSE:4568Pharmaceuticals

A Look At Daiichi Sankyo (TSE:4568) Valuation After DATROWAY Priority Review Milestone

Daiichi Sankyo Company (TSE:4568) shares are in focus after the U.S. FDA accepted and granted Priority Review to a supplemental Biologics License Application for DATROWAY in advanced triple negative breast cancer. See our latest analysis for Daiichi Sankyo Company. At a share price of ¥2,952.0, Daiichi Sankyo’s 1 day share price return of 2.89% and 7 day gain of 1.22% contrast with a 30 day share price decline of 16.66% and a 1 year total shareholder return of 19.19% in the red. This suggests...
TSE:7733
TSE:7733Medical Equipment

Olympus (TSE:7733) Valuation Check As New HR And Manufacturing Leaders Join The MedTech Push

Olympus (TSE:7733) has reshaped its senior leadership by appointing Simone Berger as Chief Human Resources Officer and David Shan as Chief Manufacturing and Supply Officer, effective April 1, 2026, following a board meeting that reviewed executive roles. See our latest analysis for Olympus. The executive reshuffle comes after a softer patch for the stock, with a 30 day share price return decline of 7.05% and a 1 year total shareholder return decline of 11.96%, while the recent 7 day share...
TSE:2413
TSE:2413Healthcare Services

Do M3’s (TSE:2413) Higher EPS Figures Hint At A Deeper Profitability Shift?

M3, Inc. has reported past earnings results for the nine months ended December 31, 2025, with sales of ¥264,395 million and net income of ¥45,237 million, both higher than a year earlier. Earnings per share from continuing operations also increased on both a basic and diluted basis, pointing to improved profitability across the existing business. Next, we will examine how this stronger profitability profile shapes M3’s investment narrative, particularly the implications of higher earnings...